Grondin R - Search Results

1

Differential regulation of striatal preproenkephalin and preprotachykinin mRNA levels in MPTP-lesioned monkeys chronically treated with dopamine D1 or D2 receptor agonists.

Morissette M, Grondin R, Goulet M, Bédard PJ, Di Paolo T. Morissette M, et al. Among authors: grondin r. J Neurochem. 1999 Feb;72(2):682-92. doi: 10.1046/j.1471-4159.1999.0720682.x. J Neurochem. 1999. PMID: 9930741 Free article.

2

Alteration of glutamate receptors in the striatum of dyskinetic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys following dopamine agonist treatment.

Calon F, Morissette M, Ghribi O, Goulet M, Grondin R, Blanchet PJ, Bédard PJ, Di Paolo T. Calon F, et al. Among authors: grondin r. Prog Neuropsychopharmacol Biol Psychiatry. 2002 Jan;26(1):127-38. doi: 10.1016/s0278-5846(01)00237-8. Prog Neuropsychopharmacol Biol Psychiatry. 2002. PMID: 11853103

3

Dyskinesia and wearing-off following dopamine D1 agonist treatment in drug-naive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned primates.

Blanchet PJ, Grondin R, Bédard PJ. Blanchet PJ, et al. Among authors: grondin r. Mov Disord. 1996 Jan;11(1):91-4. doi: 10.1002/mds.870110117. Mov Disord. 1996. PMID: 8771074

4

Dyskinesias and tolerance induced by chronic treatment with a D1 agonist administered in pulsatile or continuous mode do not correlate with changes of putaminal D1 receptors in drug-naive MPTP monkeys.

Goulet M, Grondin R, Blanchet PJ, Bédard PJ, Di Paolo T. Goulet M, et al. Among authors: grondin r. Brain Res. 1996 May 6;719(1-2):129-37. doi: 10.1016/0006-8993(96)00157-6. Brain Res. 1996. PMID: 8782872

5

Dopamine D1 receptor desensitization profile in MPTP-lesioned primates.

Blanchet PJ, Grondin R, Bédard PJ, Shiosaki K, Britton DR. Blanchet PJ, et al. Among authors: grondin r. Eur J Pharmacol. 1996 Aug 1;309(1):13-20. doi: 10.1016/0014-2999(96)00309-3. Eur J Pharmacol. 1996. PMID: 8864687

6

Cabergoline, a long-acting dopamine D2-like receptor agonist, produces a sustained antiparkinsonian effect with transient dyskinesias in parkinsonian drug-naive primates.

Grondin R, Goulet M, Di Paolo T, Bédard PJ. Grondin R, et al. Brain Res. 1996 Oct 7;735(2):298-306. doi: 10.1016/0006-8993(96)00597-5. Brain Res. 1996. PMID: 8911668

7

Potential therapeutic use of the selective dopamine D1 receptor agonist, A-86929: an acute study in parkinsonian levodopa-primed monkeys.

Grondin R, Bédard PJ, Britton DR, Shiosaki K. Grondin R, et al. Neurology. 1997 Aug;49(2):421-6. doi: 10.1212/wnl.49.2.421. Neurology. 1997. PMID: 9270571

8

Associative and limbic regions of monkey striatum express high levels of dopamine D3 receptors: effects of MPTP and dopamine agonist replacement therapies.

Morissette M, Goulet M, Grondin R, Blanchet P, Bédard PJ, Di Paolo T, Lévesque D. Morissette M, et al. Among authors: grondin r. Eur J Neurosci. 1998 Aug;10(8):2565-73. doi: 10.1046/j.1460-9568.1998.00264.x. Eur J Neurosci. 1998. PMID: 9767387

9

D1 receptor blockade improves L-dopa-induced dyskinesia but worsens parkinsonism in MPTP monkeys.

Grondin R, Doan VD, Grégoire L, Bédard PJ. Grondin R, et al. Neurology. 1999 Mar 10;52(4):771-6. doi: 10.1212/wnl.52.4.771. Neurology. 1999. PMID: 10078726

10

Antiparkinsonian effect of a new selective adenosine A2A receptor antagonist in MPTP-treated monkeys.

Grondin R, Bédard PJ, Hadj Tahar A, Grégoire L, Mori A, Kase H. Grondin R, et al. Neurology. 1999 May 12;52(8):1673-7. doi: 10.1212/wnl.52.8.1673. Neurology. 1999. PMID: 10331698

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

88 results

Search Page

Filters